购物车
- 全部删除
- 您的购物车当前为空
SL-01 is an oral derivative of gemcitabine. SL-01 inhibited human breast cancer growth through the induction of apoptosis. SL-01 inhibited human cancer growth more potently than gemcitabine.
SL-01 is an oral derivative of gemcitabine. SL-01 inhibited human breast cancer growth through the induction of apoptosis. SL-01 inhibited human cancer growth more potently than gemcitabine.
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
250 mg | ¥ 647 | 35日内发货 | |
500 mg | ¥ 1,190 | 35日内发货 | |
1 g | ¥ 1,620 | 35日内发货 |
产品描述 | SL-01 is an oral derivative of gemcitabine. SL-01 inhibited human breast cancer growth through the induction of apoptosis. SL-01 inhibited human cancer growth more potently than gemcitabine. |
别名 | Z-Phe-chloromethylketone, ZLPhe chloromethyl ketone, Z L Phe chloromethyl ketone, NSC-251810 |
分子量 | 331.79 |
分子式 | C18H18ClNO3 |
CAS No. | 26049-94-5 |
密度 | 1.1630 g/cm3 (Estimated) |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
溶解度信息 | DMSO: Soluble |
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容